← Leaderboards
Eric Joseph Rubin
University Of Pittsburgh At Pittsburgh
$20,208,402
Attributed
$57,901,858
Total exposure
24
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $10.8M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$71,150,550 · 25
By mechanism
U19$49,407,169 · 10
R01$14,353,429 · 6
P01$3,794,992 · 2
T32$1,657,382 · 2
U01$1,097,241 · 1
R21$806,837 · 2
Top collaborators
- Darrell P Chandler31 shared
- Aedin C Culhane31 shared
- Molly Forrest Franke31 shared
- Jerome Timothy Galea31 shared
- Anne Goldfeld31 shared
- Louise Catherine Ivers31 shared
- Ann Chesney Miller31 shared
- Nira Pollock31 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Graham F. Hatfull$17,993,179
- Sharon Riddler$22,034,939
- Joanne L. Flynn$43,717,509
- Anil Kumar Ojha$4,738,622
- Krista Gabrielle Freeman$448,970
Others in their field
Top investigators on “Mycobacterium Tuberculosis”
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$267,251,837
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Kevin Urdahl · Seattle Children'S Hospital$86,597,961
- David Alland · Rutgers Biomedical And Health Sciences$70,943,567
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- William Robert Jacobs · Albert Einstein College Of Medicine$43,123,310
Research focus
Mycobacterium TuberculosisBaseDrug ResistanceTuberculosisGeneticPharmaceutical PreparationsInnovationGenesProteinsMutantIn VitroMolecularInfectionGrowthCellsDiagnosisMycobacterialProgramsPhenotypeResourcesDiagnosticMutationTechnologyDesign
Grant awards (105)
Molecular mechanisms of inherent drug resistance in non-tuberculous mycobacteria$768,176
R01 · FY2025 · AI · contact PI
Molecular mechanisms of inherent drug resistance in non-tuberculous mycobacteria$768,176
R01 · FY2024 · AI · contact PI
Development of a Self Inactivating, Highly Effective TB Vaccine$786,054
R01 · FY2023 · AI
Molecular mechanisms of inherent drug resistance in non-tuberculous mycobacteria$759,743
R01 · FY2023 · AI · contact PI
Discovery of inhibitors that target the Mtb ClpP1P2 protease$434,877
U19 · FY2023 · AI · contact PI
The Graduate Program in Tropical Infectious Diseases (GPiTID)$207,831
T32 · FY2023 · AI
Discovery of inhibitors that target the Mtb ClpP1P2 protease$850,917
U19 · FY2022 · AI · contact PI
Development of a Self Inactivating, Highly Effective TB Vaccine$787,367
R01 · FY2022 · AI
Core A - Chemigenomics$354,770
P01 · FY2022 · AI · contact PI
The Graduate Program in Tropical Infectious Diseases (GPiTID)$202,834
T32 · FY2022 · AI
Using genetics and multi-scale imaging to understand the mechanisms underlying mycobacteriophage host choice$197,175
R21 · FY2022 · AI · contact PI
Development of a Self Inactivating, Highly Effective TB Vaccine$807,595
R01 · FY2021 · AI
Discovery of inhibitors that target the Mtb ClpP1P2 protease$434,878
U19 · FY2021 · AI · contact PI
Core A - Chemigenomics$360,022
P01 · FY2021 · AI · contact PI
Using genetics and multi-scale imaging to understand the mechanisms underlying mycobacteriophage host choice$250,961
R21 · FY2021 · AI · contact PI
The Graduate Program in Tropical Infectious Diseases (GPiTID)$193,428
T32 · FY2021 · AI
Development of a Self Inactivating, Highly Effective TB Vaccine$780,015
R01 · FY2020 · AI
Discovery of inhibitors that target the Mtb ClpP1P2 protease$522,353
U19 · FY2020 · AI · contact PI
Core A - Chemigenomics$361,380
P01 · FY2020 · AI · contact PI
The Graduate Program in Tropical Infectious Diseases (GPiTID)$189,894
T32 · FY2020 · AI
Development of a Self Inactivating, Highly Effective TB Vaccine$721,271
R01 · FY2019 · AI
Discovery of inhibitors that target the Mtb ClpP1P2 protease$542,890
U19 · FY2019 · AI · contact PI
Core A - Chemigenomics$358,507
P01 · FY2019 · AI · contact PI
The Graduate Program in Tropical Infectious Diseases (GPiTID)$178,549
T32 · FY2019 · AI
Sequencing Core$2,595,356
U19 · FY2018 · AI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$1,274,314
U19 · FY2018 · AI
Discovery and validation of drug resistance mutations$938,261
U19 · FY2018 · AI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children$888,730
U19 · FY2018 · AI
Core A - Chemigenomics$415,025
P01 · FY2018 · AI · contact PI
Administrative Core$412,046
U19 · FY2018 · AI
Integrated system for Category C infectious disease diagnostics in resource-limi$403,448
U19 · FY2018 · AI
Decoding the roles of critical genes of unknown function in M. tuberculosis$2,581,462
U19 · FY2017 · AI · contact PI
Integrated system for Category C infectious disease diagnostics in resource-limi$2,182,203
U19 · FY2017 · AI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children$1,095,803
U19 · FY2017 · AI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$913,253
U19 · FY2017 · AI
Discovery and validation of drug resistance mutations$734,112
U19 · FY2017 · AI
Administrative Core$616,131
U19 · FY2017 · AI
Sequencing Core$408,777
U19 · FY2017 · AI
Administrative Core$309,494
U19 · FY2017 · AI · contact PI
The roles of genes critical for growth under defined conditions in vitro or duri$161,656
U19 · FY2017 · AI · contact PI
Decoding the roles of critical genes of unknown function in M. tuberculosis$2,581,462
U19 · FY2016 · AI · contact PI
Integrated system for Category C infectious disease diagnostics in resource-limi$2,528,705
U19 · FY2016 · AI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children$992,134
U19 · FY2016 · AI
Discovery and validation of drug resistance mutations$750,894
U19 · FY2016 · AI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$715,308
U19 · FY2016 · AI
A Community Mycobacterial Systems Resource$662,260
R01 · FY2016 · AI
The roles of genes critical for growth under defined conditions in vitro or duri$593,390
U19 · FY2016 · AI · contact PI
Sequencing Core$421,675
U19 · FY2016 · AI
Administrative Core$410,524
U19 · FY2016 · AI
Fate of M. tuberculosis Antibiotic Survivors$176,991
R21 · FY2016 · AI
Administrative Core$113,816
U19 · FY2016 · AI · contact PI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$82,633
U19 · FY2016 · AI
Decoding the roles of critical genes of unknown function in M. tuberculosis$2,782,563
U19 · FY2015 · AI · contact PI
Integrated system for Category C infectious disease diagnostics in resource-limi$2,500,809
U19 · FY2015 · AI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children$932,090
U19 · FY2015 · AI
Discovery and validation of drug resistance mutations$774,241
U19 · FY2015 · AI
The roles of genes critical for growth under defined conditions in vitro or duri$672,898
U19 · FY2015 · AI · contact PI
A Community Mycobacterial Systems Resource$662,260
R01 · FY2015 · AI
Sequencing Core$660,525
U19 · FY2015 · AI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$500,331
U19 · FY2015 · AI
'Chemical & Genetic Approaches to Defining & Validating Vulnerable Mycobact Targ$495,995
P01 · FY2015 · AI · contact PI
Administrative Core$311,434
U19 · FY2015 · AI
Fate of M. tuberculosis Antibiotic Survivors$181,710
R21 · FY2015 · AI
Administrative Core$160,503
U19 · FY2015 · AI · contact PI
Integrated system for Category C infectious disease diagnostics in resource-limi$2,916,905
U19 · FY2014 · AI
Decoding the roles of critical genes of unknown function in M. tuberculosis$2,581,322
U19 · FY2014 · AI · contact PI
Innovative Strategies to Improve Tuberculosis Diagnostics in Children$900,727
U19 · FY2014 · AI
Sequencing Core$822,385
U19 · FY2014 · AI
A Community Mycobacterial Systems Resource$702,919
R01 · FY2014 · AI
Discovery and validation of drug resistance mutations$554,926
U19 · FY2014 · AI
Genetic determinants of drug resistance in Mycobacteria tuberculosis$536,059
U19 · FY2014 · AI
The roles of genes critical for growth under defined conditions in vitro or duri$521,480
U19 · FY2014 · AI · contact PI
'Chemical & Genetic Approaches to Defining & Validating Vulnerable Mycobact Targ$501,541
P01 · FY2014 · AI · contact PI
Administrative Core$225,640
U19 · FY2014 · AI
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors$213,349
U01 · FY2014 · GM · contact PI
Immunology and Infectious Diseases$162,162
T32 · FY2014 · AI · contact PI
Administrative Core$114,183
U19 · FY2014 · AI · contact PI
Decoding the roles of critical genes of unknown function in M. tuberculosis$2,721,883
U19 · FY2013 · AI · contact PI
The roles of genes critical for growth under defined conditions in vitro or duri$612,109
U19 · FY2013 · AI · contact PI
A Community Mycobacterial Systems Resource$586,056
R01 · FY2013 · AI
'Chemical & Genetic Approaches to Defining & Validating Vulnerable Mycobact Targ$446,590
P01 · FY2013 · AI · contact PI
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors$205,734
U01 · FY2013 · GM · contact PI
Immunology and Infectious Diseases$181,642
T32 · FY2013 · AI · contact PI
Administrative Core$112,654
U19 · FY2013 · AI · contact PI
A Community Mycobacterial Systems Resource$565,167
R01 · FY2012 · AI
'Chemical & Genetic Approaches to Defining & Validating Vulnerable Mycobact Targ$501,162
P01 · FY2012 · AI · contact PI
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors$225,212
U01 · FY2012 · GM · contact PI
Immunology and Infectious Diseases$166,512
T32 · FY2012 · AI · contact PI
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors$212,843
U01 · FY2011 · GM · contact PI
Immunology and Infectious Diseases$174,530
T32 · FY2011 · AI · contact PI
Drug Targets for Tuberculosis$395,514
R01 · FY2010 · AI · contact PI
Structures of Mtb proteins conferring susceptibility to known Mtb inhibitors$240,103
U01 · FY2010 · GM · contact PI
Drug Targets for Tuberculosis$406,091
R01 · FY2009 · AI · contact PI
2009 Tuberculosis Drug Development GRC$16,500
R13 · FY2009 · AI · contact PI
2007 GRC on TB Drug Development$17,000
R13 · FY2007 · AI · contact PI
Drug resistance in tuberculosis: genetic and dynamics$485,400
R01 · FY2005 · AI
Virulence Factors in Mycobacteria$364,050
R01 · FY2005 · AI
Drug resistance in tuberculosis: genetic and dynamics$485,400
R01 · FY2004 · AI
Virulence Factors in Mycobacteria$364,050
R01 · FY2004 · AI
Drug resistance in tuberculosis: genetic and dynamics$485,400
R01 · FY2003 · AI
Virulence Factors in Mycobacteria$364,050
R01 · FY2003 · AI
Drug resistance in tuberculosis: genetic and dynamics$412,590
R01 · FY2002 · AI
Virulence Factors in Mycobacteria$364,050
R01 · FY2002 · AI
Drug resistance in tuberculosis--Genetic and dynamics$485,500
R01 · FY2001 · AI
Virulence Factors in Mycobacteria$384,275
R01 · FY2001 · AI